IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B Cell subpopulation: Characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells

Yonsei Medical Journal

Volumn 52, Issue 5, 2011, Pages 851-855

  Lee, Jae Ho ^a   Noh, Joonyong ^b   Noh, Geunwoong ^c   Choi, Wahn Soo ^d   Lee, Sang Sun ^e  

^a Chungnam National University   (South Korea)

^b Konkuk University   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Konkuk University   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

CD19; CD5; CD5(+) B; IL 10; Regulatory B cell

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTIGENS, CD19; ANTIGENS, CD5; APOPTOSIS; B-LYMPHOCYTE SUBSETS; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10;

EID: 79960119139     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.5.851     Document Type: Article

References (19)

1. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006;176:705-10.
2. Gieni RS, Umetsu DT, DeKruyff RH. Ly1-(CD5-) B cells produce interleukin (IL)-10. Cell Immunol 1997;175:164-70.
3. Lee JH, Noh J, Noh G, Kim HS, Mun SH, Choi WS, et al. Allergen-specific B cell subset responses in cow's milk allergy of late eczematous reactions in atopic dermatitis. Cell Immunol 2010; 262:44-51.
4. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009;182:7459-72.
5. Fujimoto M, Sato S. B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci 2007;46:1-9.
6. Tedder TF, Isaacs CM. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 1989;143:712-7.
7. Matsushita T, Fujimoto M, Hasegawa M, Komura K, Takehara K, Tedder TF, et al. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol 2006;168:812-21.
8. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010; 40:2686-91.
9. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2008;29:34-40.
10. Noh J, Lee JH, Noh G, Bang SY, Kim HS, Choi WS, et al. Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy. Cell Immunol 2010; 264:143-9.
11. Taylor DK, Ito E, Thorn M, Sundar K, Tedder T, Spatz LA. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19. Mol Immunol 2006;43:1776-90.
12. Sato S, Steeber DA, Jansen PJ, Tedder TF. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J Immunol 1997;158:4662-9.
13. Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, et al. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J Immunol 2005;175:8011-23.
14. Sato S, Miller AS, Howard MC, Tedder TF. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J Immunol 1997;159:3278-87.
15. Shoham T, Rajapaksa R, Boucheix C, Rubinstein E, Poe JC, Tedder TF, et al. The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J Immunol 2003;171:4062-72.
16. Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 1999;162:7088-94.
17. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010;1183:38-57.
18. Garaud S, Le Dantec C, de Mendoza AR, Mageed RA, Youinou P, Renaudineau Y. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann N Y Acad Sci 2009;1173:280-5.
19. Díaz-Alderete A, Crispin JC, Vargas-Rojas MI, Alcocer-Varela J. IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus. J Autoimmun 2004;23:379-83.